These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5368430)

  • 1. [Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
    Dressel H; Richter J
    Pharmazie; 1969 Sep; 24(9):555-66. PubMed ID: 5368430
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the biological value of liver-protective agents with special reference to liver preparations. 8. Description of the method for the biological evaluation of preventive and therapeutic liver-protective agents].
    Dressel H
    Z Med Labortech; 1969; 10(6):371-84. PubMed ID: 5405586
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Critical assessment of the value of liver protection therapy].
    Rinetti M; Dei Cas L
    Minerva Gastroenterol; 1974; 20(3):90-6. PubMed ID: 4467044
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical work on a new drug combination used in liver diseases and its consequences].
    Naufal J
    Hospital (Rio J); 1969 Apr; 75(4):1469-82. PubMed ID: 5306437
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatoprotective action of total liver extract combined with vitamin B 12 vitamin E, and vitamin K in the course of treatment with multiple mycobacterial agents in patients with tuberculosis with chronic liver disease].
    D'Angelo G; Salatino A
    Clin Ter; 1970 Jan; 52(1):61-70. PubMed ID: 5525554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report on the experiences in the ambutant treatment of hepatopathy with Heparhormforte].
    Ignatius A
    Landarzt; 1965 Sep; 41(25):1090-2. PubMed ID: 5857646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Heinrich HC
    Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Wildhirt E
    Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases].
    Rottini E; Scianaro L
    Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acne vulgaris and liver preparations. A contribution to the etiology of acne vulgaris].
    Amann W
    Z Haut Geschlechtskr; 1965 Jul; 39(1):28-30. PubMed ID: 4220931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 16. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.